Mylan N.V.

Mylan N.V. is a global pharmaceutical company known for producing generic and specialty medications. Founded in 1961, it focuses on making affordable drugs available worldwide, including medications for conditions like allergies, infections, and chronic diseases. Mylan gained significant attention for its epinephrine auto-injector, EpiPen, which is used to treat severe allergic reactions. The company became part of Viatris in 2020 after merging with Upjohn, a division of Pfizer, enhancing its ability to deliver a broad range of healthcare solutions. Mylan is committed to improving access to medicines and addressing public health challenges globally.